Bob Martin Easy to Use Wormer Granules for Large Dogs

Ülke: İrlanda

Dil: İngilizce

Kaynak: HPRA (Health Products Regulatory Authority)

Aktif bileşen:

Fenbendazole

Mevcut itibaren:

Chanelle Pharmaceuticals Manufacturing Limited

ATC kodu:

QP52AC13

INN (International Adı):

Fenbendazole

Doz:

222.2 milligram(s)/gram

Farmasötik formu:

Granules

Reçete türü:

CAM: Companion Animal Medicine as defined in relevant national legislation

Terapötik grubu:

Dogs

Terapötik alanı:

fenbendazole

Terapötik endikasyonlar:

Endoparasiticide

Yetkilendirme durumu:

Authorised

Yetkilendirme tarihi:

1997-06-27

Ürün özellikleri

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Bob Martin Easy to Use Wormer Granules for Large Dogs
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
ACTIVE SUBSTANCE
Fenbendazole
222.2mg/g
For a full list of excipients see section 6.1.
3 PHARMACEUTICAL FORM
Granules
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Dogs.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment of immature and mature stages of nematodes of the
gastro-intestinal and respiratory tracts of domestic
dogs.
It also has an ovicidal effect and is indicated for the following:
For the treatment of gastrointestinal nematodes and cestodes of
domestic dogs affected with_ Ascarid_ spp.,_ Ancylostoma_
spp.,_ Uncinaria_ spp.,_ Trichuris_ spp., and_ Taenia_ spp.
Also for the treatment of lungworm nematodes of domestic dogs
affected with_ Oslerus (Filariodes) osleri_.
4.3 CONTRAINDICATIONS
Do not use in cases of known hypersensitivity to active substance.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
Do not administer to sick or convalescing animals.
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
If signs of disease persist or appear consult your veterinary surgeon
or veterinary practitioner.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE
PRODUCT TO ANIMALS
Direct contact with the skin should be kept to a minimum.
Avoid inhalation of granule dust. Wash hands after use.
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_3_
_1_
_/_
_0_
_7_
_/_
_2_